News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,907 Results
Type
Article (7103)
Company Profile (33)
Press Release (276769)
Multimedia
Podcasts (7)
Webinars (8)
Section
Business (94170)
Career Advice (565)
Deals (17807)
Drug Delivery (23)
Drug Development (23823)
Employer Resources (40)
FDA (4754)
Job Trends (5211)
News (142182)
Policy (10515)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (416)
Accelerated approval (13)
Adcomms (4)
Allergies (35)
Alliances (18252)
ALS (60)
Alzheimer's disease (444)
Antibody-drug conjugate (ADC) (94)
Approvals (4949)
Artificial intelligence (233)
Autoimmune disease (86)
Automation (14)
Bankruptcy (130)
Best Places to Work (3946)
BIOSECURE Act (3)
Biosimilars (55)
Biotechnology (31)
Bladder cancer (59)
Brain cancer (22)
Breast cancer (237)
Cancer (1599)
Cardiovascular disease (103)
Career advice (484)
Career pathing (7)
CAR-T (81)
CDC (5)
Celiac Disease (1)
Cell therapy (243)
Cervical cancer (14)
Clinical research (21295)
Collaboration (656)
Company closure (1)
Compensation (476)
Complete response letters (19)
COVID-19 (555)
CRISPR (18)
C-suite (544)
Cystic fibrosis (44)
Data (2317)
Denatured (6)
Depression (40)
Dermatology (30)
Diabetes (143)
Diagnostics (2744)
Digital health (24)
Diversity (2)
Diversity, equity & inclusion (15)
Drug discovery (78)
Drug pricing (25)
Drug shortages (4)
Duchenne muscular dystrophy (68)
Earnings (48233)
Editorial (6)
Employer branding (6)
Employer resources (40)
Events (45685)
Executive appointments (562)
FDA (5923)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (7)
Frontotemporal dementia (14)
Funding (513)
Gene editing (43)
Generative AI (12)
Gene therapy (177)
GLP-1 (228)
Government (786)
Grass and pollen (2)
Guidances (246)
Healthcare (6364)
HIV (17)
Huntington's disease (8)
IgA nephropathy (23)
Immunology and inflammation (53)
Immuno-oncology (25)
Indications (47)
Infectious disease (607)
Inflammatory bowel disease (45)
Inflation Reduction Act (5)
Influenza (15)
Intellectual property (63)
Interviews (68)
IPO (9180)
IRA (5)
Job creations (1358)
Job search strategy (432)
JPM (8)
Kidney cancer (14)
Labor market (18)
Layoffs (139)
Leadership (10)
Legal (3060)
Liver cancer (26)
Longevity (7)
Lung cancer (190)
Lymphoma (107)
Machine learning (13)
Management (16)
Manufacturing (325)
MASH (64)
Medical device (5225)
Medtech (5267)
Mergers & acquisitions (9275)
Metabolic disorders (341)
mRNA (20)
Multiple sclerosis (50)
NASH (6)
Neurodegenerative disease (94)
Neuropsychiatric disorders (20)
Neuroscience (855)
NextGen: Class of 2026 (2163)
Non-profit (908)
Now hiring (20)
Obesity (126)
Opinion (62)
Ovarian cancer (56)
Pain (53)
Pancreatic cancer (78)
Parkinson's disease (80)
Partnered (19)
Patents (112)
Patient recruitment (166)
Peanut (8)
People (29494)
Pharmaceutical (12)
Pharmacy benefit managers (2)
Phase 1 (6220)
Phase 2 (9405)
Phase 3 (7403)
Pipeline (3862)
Policy (40)
Postmarket research (748)
Preclinical (2432)
Press Release (67)
Prostate cancer (90)
Psychedelics (6)
Radiopharmaceuticals (154)
Rare diseases (291)
Real estate (2295)
Recruiting (12)
Regulatory (8153)
Reports (20)
Research institute (434)
Resumes & cover letters (85)
Rett syndrome (30)
RNA editing (5)
RSV (4)
Schizophrenia (75)
Series A (76)
Series B (70)
Service/supplier (2)
Sickle cell disease (18)
Special edition (1)
Spinal muscular atrophy (44)
Sponsored (20)
Startups (1210)
State (1)
Stomach cancer (2)
Supply chain (33)
Tariffs (11)
The Weekly (1)
Vaccines (197)
Venture capital (18)
Weight loss (47)
Women's health (28)
Worklife (4)
Date
Today (70)
Last 7 days (193)
Last 30 days (1411)
Last 365 days (11488)
2026 (5161)
2025 (11563)
2024 (13899)
2023 (16172)
2022 (22159)
2021 (23816)
2020 (21939)
2019 (16669)
2018 (12771)
2017 (12260)
2016 (11253)
2015 (14527)
2014 (11365)
2013 (9263)
2012 (10043)
2011 (10447)
2010 (10047)
Location
Africa (232)
Alabama (26)
Alaska (3)
Arizona (106)
Arkansas (3)
Asia (14574)
Australia (2040)
California (4992)
Canada (2224)
China (325)
Colorado (223)
Connecticut (219)
Delaware (105)
Europe (30948)
Florida (841)
Georgia (135)
Idaho (30)
Illinois (280)
India (36)
Indiana (251)
Iowa (9)
Japan (253)
Kansas (52)
Kentucky (21)
Louisiana (13)
Maine (60)
Maryland (515)
Massachusetts (3767)
Michigan (173)
Minnesota (286)
Mississippi (1)
Missouri (45)
Montana (19)
Nebraska (14)
Nevada (70)
New Hampshire (29)
New Jersey (1645)
New Mexico (12)
New York (1294)
North Carolina (725)
North Dakota (5)
Northern California (2602)
Ohio (171)
Oklahoma (10)
Oregon (7)
Pennsylvania (943)
Puerto Rico (10)
Rhode Island (21)
South America (368)
South Carolina (22)
Southern California (1911)
Tennessee (98)
Texas (872)
United States (18228)
Utah (147)
Virginia (122)
Washington D.C. (23)
Washington State (417)
West Virginia (2)
Wisconsin (92)
Wyoming (2)
283,907 Results for "sharps compliance corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting
April 20, 2026
·
7 min read
Press Releases
Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update
November 26, 2025
·
3 min read
Press Releases
Sharps Technology Adopts Limited Duration Stockholder Rights Plan
May 14, 2026
·
4 min read
Press Releases
Sharp Therapeutics Updates on ‘901 for Gaucher and GBA1 Parkinson’s and Platform Programs
April 10, 2026
·
4 min read
Press Releases
Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering
April 10, 2026
·
5 min read
Press Releases
Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering
April 2, 2026
·
5 min read
Press Releases
Sharp Therapeutics Corp. Reports Second Quarter 2025 Results and Expands Market Presence with Listing On OTCQB
August 29, 2025
·
4 min read
Press Releases
Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
July 22, 2025
·
1 min read
Press Releases
Sharp Therapeutics Announces Closing of Second Tranche of Unsecured Convertible Note Offering
March 13, 2026
·
5 min read
Press Releases
TriHaz Solutions Launches Direct-to-Consumer Sharps Disposal Platform to Meet Rising Demand From GLP-1 Medication Users
May 12, 2026
·
3 min read
1 of 28,391
Next
